Literature DB >> 321317

Immunocytochemical evidence for glucagon-containing cells in the human stomach.

L Munõz Barragan, C Rufener, C B Srikant, R E Dobbs, W A Shannon, D Baetens, R H Unger.   

Abstract

To determine if glucagon-containing cells could be identified in the human fundus, stomachs attained at autopsy within 4-hours of death from persons previously considered to be in good health were examined by the indirect immunoperoxidase technique using antiglucagon serum 30K. Glucagon-containing cells were demonstrated in one of eight gastric fundi examined. The glucagon content of acid alcohol extracts of the fundi examined. The glucagon content of acid alcohol extracts of the funci was low in all cases. Glucagon content was also low in canine stomach removed 4-hours after death. It is concluded that glucagon-containing cells, demonstrable by immunocytochemical techniques, may be present in the gastric fundus of humans.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321317     DOI: 10.1055/s-0028-1093580

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  8 in total

1.  Absence of islet alpha cell function in pancreatectomized patients.

Authors:  A Tiengo; M Bessioud; I Valverde; A Tabbi-Anneni; S Delprato; J Alexandre; R Assan
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

2.  Studies on persistent circulating immunoreactive glucagon (IRG) and immunoreactive insulin (IRI) found in eviscerated rats with a functional liver.

Authors:  S S Smith; S J Bhathena; D Nompleggi; J C Penhos; L Recant
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

3.  Distribution of the gut hormones in the primate intestinal tract.

Authors:  M G Bryant; S R Bloom
Journal:  Gut       Date:  1979-08       Impact factor: 23.059

4.  Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis.

Authors:  S Del Prato; F Riva; A Devidé; R Nosadini; D Fedele; A Tiengo
Journal:  Acta Diabetol Lat       Date:  1980 Apr-Jun

5.  Evidence of glucagon biosynthesis involving protein intermediates in rat salivary glands.

Authors:  A Perez Castillo; E Blazquez
Journal:  Diabetologia       Date:  1984-10       Impact factor: 10.122

6.  Synthesis and release of glucagon by human salivary glands.

Authors:  A Pérez-Castillo; E Blázquez
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122

7.  Bariatric surgery induces a new gastric mucosa phenotype with increased functional glucagon-like peptide-1 expressing cells.

Authors:  Lara Ribeiro-Parenti; Anne-Charlotte Jarry; Jean-Baptiste Cavin; Alexandra Willemetz; Johanne Le Beyec; Aurélie Sannier; Samira Benadda; Anne-Laure Pelletier; Muriel Hourseau; Thibaut Léger; Bastien Morlet; Anne Couvelard; Younes Anini; Simon Msika; Jean-Pierre Marmuse; Sévérine Ledoux; Maude Le Gall; André Bado
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

8.  Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme-linked immunosorbent assay.

Authors:  Toshihiro Matsuo; Jun-Ichiro Miyagawa; Yoshiki Kusunoki; Masayuki Miuchi; Takashi Ikawa; Takafumi Akagami; Masaru Tokuda; Tomoyuki Katsuno; Akira Kushida; Takashi Inagaki; Mitsuyoshi Namba
Journal:  J Diabetes Investig       Date:  2015-08-24       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.